Mayne Pharma Group Limited Price Chart
Mayne Pharma Group Limited MYX.XA Financial and Trading Overview
| Mayne Pharma Group Limited stock price | 6.24 AUD |
| Previous Close | 3.86 AUD |
| Open | 3.89 AUD |
| Bid | 3.86 AUD x N/A |
| Ask | 3.89 AUD x N/A |
| Day's Range | 3.72 - 3.94 AUD |
| 52 Week Range | 2.68 - 8.5 AUD |
| Volume | 4.27M AUD |
| Avg. Volume | 53.86K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.992337 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.048 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MYX.XA Valuation Measures
| Enterprise Value | 263.95M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.42911786 |
| Enterprise Value/Revenue | 0.703 |
| Enterprise Value/EBITDA | -3.119 |
Trading Information
Mayne Pharma Group Limited Stock Price History
| Beta (5Y Monthly) | 0.992337 |
| 52-Week Change | -17.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.5 AUD |
| 52 Week Low | 2.68 AUD |
| 50-Day Moving Average | 3.91 AUD |
| 200-Day Moving Average | 4.53 AUD |
MYX.XA Share Statistics
| Avg. Volume (3 month) | 53.86K AUD |
| Avg. Daily Volume (10-Days) | 57.09K AUD |
| Shares Outstanding | N/A |
| Float | 60.52M |
| Short Ratio | N/A |
| % Held by Insiders | 24.82% |
| % Held by Institutions | 16.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.05:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 20.51% |
| Operating Margin (ttm) | -39.92% |
| Gross Margin | 30.43% |
| EBITDA Margin | -22.53% |
Management Effectiveness
| Return on Assets (ttm) | -6.32% |
| Return on Equity (ttm) | -43.54% |
Income Statement
| Revenue (ttm) | 375.56M AUD |
| Revenue Per Share (ttm) | 4.53 AUD |
| Quarterly Revenue Growth (yoy) | -32.70% |
| Gross Profit (ttm) | 171.03M AUD |
| EBITDA | -84641000 AUD |
| Net Income Avi to Common (ttm) | -326335008 AUD |
| Diluted EPS (ttm) | -0.048 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 175.54M AUD |
| Total Cash Per Share (mrq) | 1.99 AUD |
| Total Debt (mrq) | 81.23M AUD |
| Total Debt/Equity (mrq) | 10.18 AUD |
| Current Ratio (mrq) | 1.454 |
| Book Value Per Share (mrq) | 9.046 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -64414000 AUD |
| Levered Free Cash Flow (ttm) | -150407872 AUD |
Profile of Mayne Pharma Group Limited
| Country | Australia |
| State | SA |
| City | Salisbury South |
| Address | 1538 Main North Road |
| ZIP | 5106 |
| Phone | 61 8 8209 2666 |
| Website | https://www.maynepharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Q&A For Mayne Pharma Group Limited Stock
What is a current MYX.XA stock price?
Mayne Pharma Group Limited MYX.XA stock price today per share is 6.24 AUD.
How to purchase Mayne Pharma Group Limited stock?
You can buy MYX.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mayne Pharma Group Limited?
The stock symbol or ticker of Mayne Pharma Group Limited is MYX.XA.
How many shares does Mayne Pharma Group Limited have in circulation?
The max supply of Mayne Pharma Group Limited shares is 0.
What is Mayne Pharma Group Limited Price to Earnings Ratio (PE Ratio)?
Mayne Pharma Group Limited PE Ratio is now.
What was Mayne Pharma Group Limited earnings per share over the trailing 12 months (TTM)?
Mayne Pharma Group Limited EPS is -0.048 AUD over the trailing 12 months.